Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging

키워드

참고문헌 (80)

1. Corbo RM, "Structural and phylogenetic approaches to assess the significance of human Apolipoprotein E variation", Mol Genet Metab, 89, pp.261~269 (2006)
2. Nickerson DA, "Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene", Genome Res, 10, pp.1532~1545 (2000)
3. 박창훈, "Discrepancy in Genotyping of Apolipoprotein E between Allele-Specific PCR and Fluorescence Resonance Energy Transfer or Sequencing", Annals of Laboratory Medicine, 30(3), pp.325~328 (2010), 대한진단검사의학회
4. Scacchi R, "Screening of two mutations at exon 3 of the apolipoprotein E gene(sites 28 and 42)in a sample of patients with sporadic late-onset Alzheimer’s disease", Neurobiol Aging, 24, pp.339~343 (2003)
5. Wernette-Hammond ME, "Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194", J Biol Chem, 264, pp.9094~9101 (1989)
6. Weisgraber KH, "Apolipoprotein E : structure-function relationships", Adv Protein Chem, 45, pp.249~302 (1994)
7. Mahley RW, "Apolipoprotein e sets the stage : response to injury triggers neuropathology", Neuron, 76, pp.871~885 (2012)
8. Mahley RW, "Apolipoprotein E : from atherosclerosis to Alzheimer’s disease and beyond", Curr Opin Lipidol, 10, pp.207~217 (1999)
9. Mahley RW, "Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS", J Lipid Res, 50(Suppl), pp.S183~S188 (2009)
10. Zhang H, "Cross-talk between apolipoprotein E and cytokines", Mediators Inflamm, 2011, pp.949072~ (2011)
11. Jaekwang Kim, "Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms", Molecules and Cells, 37(11), pp.767~776 (2014), 한국분자세포생물학회
12. Xu Q, "Profile and regulation of apolipoprotein E(ApoE)expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus", J Neurosci, 26, pp.4985~4994 (2006)
13. Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families", Science, 261, pp.921~923 (1993)
14. Rebeck GW, "Apolipoprotein E and Alzheimer’s disease : the protective effects of ApoE2 and E3", J Alzheimers Dis, 4, pp.145~154 (2002)
15. Villeneuve S, "The potential applications of Apolipoprotein E in personalized medicine", Front Aging Neurosci, 6, pp.154~ (2014)
16. Farrer LA, "Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium", JAMA, 278, pp.1349~1356 (1997)
17. van Duijn CM, "Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease", Nat Genet, 7, pp.74~78 (1994)
18. Kwon OD, "Apolipoprotein E polymorphism and age at onset of Alzheimer’s disease in a quadriethnic sample", Dement Geriatr Cogn Disord, 30, pp.486~491 (2010)
19. Corder EH, "Protective effect of apolipoprotein E type 2allele for late onset Alzheimer disease", Nat Genet, 7, pp.180~184 (1994)
20. Wu YN, "An association analysis of apolipoprotein E genotypes with Alzheimer’s disease in Chinese population", Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 23, pp.450~454 (2001)
21. Mahley RW, "Alzheimer disease : multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches", Ann Neurol, 65, pp.623~625 (2009)
22. Raffai RL, "Introduction of human apolipoprotein E4"domain interaction"into mouse apolipoprotein E", Proc Natl Acad Sci U S A, 98, pp.11587~11591 (2001)
23. Ye S, "Apolipoprotein(apo)E4 enhances amyloid beta peptide production in cultured neuronal cells : apoE structure as a potential therapeutic target", Proc Natl Acad Sci U S A, 102, pp.18700~18705 (2005)
24. Hatters DM, "Apolipoprotein E structure : insights into function", Trends Biochem Sci, 31, pp.445~454 (2006)
25. Rohn TT, "Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer’s disease", Int J Mol Sci, 14, pp.14908~14922 (2013)
26. Rohn TT, "Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer’s disease brain", Brain Res, 1475, pp.106~115 (2012)
27. Chang S, "Lipid-and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity", Proc Natl Acad Sci U S A, 102, pp.18694~18699 (2005)
28. Rubinsztein DC, "The genetics of Alzheimer’s disease", Prog Neurobiol, 52, pp.447~454 (1997)
29. R. E. Tanzi, "The Genetics of Alzheimer Disease", Cold Spring Harbor Perspectives in Medicine, 2(10), pp.a006296~a006296 (2012), Cold Spring Harbor Laboratory[DOI]
30. Raichlen DA, "Exercise, APOE genotype, and the evolution of the human lifespan", Trends Neurosci, 37, pp.247~255 (2014)
31. Golde TE, "Biochemical detection of Abeta isoforms : implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease", Biochim Biophys Acta, 1502, pp.172~187 (2000)
32. Lee VM, "The disordered neuronal cytoskeleton in Alzheimer’s disease", Curr Opin Neurobiol, 2, pp.653~656 (1992)
33. Golde TE, "Targeting Abeta and tau in Alzheimer’s disease, an early interim report", Exp Neurol, 223, pp.252~266 (2010)
34. Selkoe DJ, "Clearing the brain’s amyloid cobwebs", Neuron, 32, pp.177~180 (2001)
35. Selkoe DJ, "Alzheimer’s disease : genes, proteins, and therapy", Physiol Rev, 81, pp.741~766 (2001)
36. Vemuri P, "Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease", Ann Neurol, 67, pp.308~316 (2010)
37. Harris FM, "Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase : modulation by zinc", J Biol Chem, 279, pp.44795~44801 (2004)
38. Tesseur I, "Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice", Am J Pathol, 156, pp.951~964 (2000)
39. Agosta F, "Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer’s disease and frontotemporal dementia", Proc Natl Acad Sci U S A, 106, pp.2018~2022 (2009)
40. Stancu IC, "Models of β-amyloid induced Tau-pathology : the long and"folded"road to understand the mechanism", Mol Neurodegener, 9, pp.51~ (2014)
41. Inbar D, "Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade", Neurodegener Dis, 7, pp.16~23 (2010)
42. Hardy J, "The amyloid hypothesis of Alzheimer’s disease : progress and problems on the road to therapeutics", Science, 297, pp.353~356 (2002)
43. Braak H, "Neuropathological stageing of Alzheimer-related changes", Acta Neuropathol, 82, pp.239~259 (1991)
44. Frisoni GB, "Mapping local hippocampal changes in Alzheimer’s disease and normal ageing with MRI at 3 Tesla", Brain, 131(Pt 12), pp.3266~3276 (2008)
45. Sabri O, "Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer’s disease : phase 3 study", Alzheimers Dement, 11, pp.964~974 (2015)
46. Rusinek H, "Regional brain atrophy rate predicts future cognitive decline : 6-year longitudinal MR imaging study of normal aging", Radiology, 229, pp.691~696 (2003)
47. McGowan E, "Abeta42 is essential for parenchymal and vascular amyloid deposition in mice", Neuron, 47, pp.191~199 (2005)
48. Mori E, "Accelerated hippocampal atrophy in Alzheimer’s disease with apolipoprotein E epsilon4 allele", Ann Neurol, 51, pp.209~214 (2002)
49. Strittmatter WJ, "Apolipoprotein E : high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease", Proc Natl Acad Sci U S A, 90, pp.1977~1981 (1993)
50. Strittmatter WJ, "Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau : implications for Alzheimer disease", Proc Natl Acad Sci U S A, 91, pp.11183~11186 (1994)
51. Sunderland T, "Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer’s disease : the effect of APOE epsilon4 allele", Biol Psychiatry, 56, pp.670~676 (2004)
52. Walsh DM, "Deciphering the molecular basis of memory failure in Alzheimer’s disease", Neuron, 44, pp.181~193 (2004)
53. Conforti L, "Neuronal death : where does the end begin?", Trends Neurosci, 30, pp.159~166 (2007)
54. Rhinn H, "Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease", Nature, 500, pp.45~50 (2013)
55. Desikan RS, "The role of clusterin in amyloid-β-associated neurodegeneration", JAMA Neurol, 71, pp.180~187 (2014)
56. Albuquerque MS, "Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer’s disease", Front Aging Neurosci, 7, pp.30~ (2015)
57. Goutagny R, "Hippocampal oscillatory activity in Alzheimer’s disease : toward the identification of early biomarkers?", Aging Dis, 4, pp.134~140 (2013)
58. Roberson ED, "Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model", Science, 316, pp.750~754 (2007)
59. Seward ME, "Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer’s disease", J Cell Sci, 126(Pt 5), pp.1278~1286 (2013)
60. Lane-Donovan C, "More than cholesterol transporters : lipoprotein receptors in CNS function and neurodegeneration", Neuron, 83, pp.771~787 (2014)
61. Krstic D, "Deciphering the mechanism underlying late-onset Alzheimer disease", Nat Rev Neurol, 9, pp.25~34 (2013)
62. Kim DH, "Genetic markers for diagnosis and pathogenesis of Alzheimer’s disease", Gene, 545, pp.185~193 (2014)
63. Leduc V, "Function and comorbidities of apolipoprotein e in Alzheimer’s disease", Int J Alzheimers Dis, 2011, pp.974361~ (2011)
64. D’Onofrio G, "Neuropsychiatric symptoms and functional status in Alzheimer’s disease and vascular dementia patients", Curr Alzheimer Res, 9, pp.759~771 (2012)
65. Chen CH, "A comparative study to screen dementia and APOE genotypes in an ageing East African population", Neurobiol Aging, 31, pp.732~740 (2010)
66. Mawuenyega KG, "Decreased clearance of CNS beta-amyloid in Alzheimer’s disease", Science, 330, pp.1774~ (2010)
67. Castellano JM, "Human apoE isoforms differentially regulate brain amyloid-β peptide clearance", Sci Transl Med, 3, pp.89ra57~ (2011)
68. Tang MX, "The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics", JAMA, 279, pp.751~755 (1998)
69. Hendrie HC, "International studies in dementia with particular emphasis on populations of African origin", Alzheimer Dis Assoc Disord, 20(3 Suppl 2), pp.S42~S46 (2006)
70. Evans DA, "Incidence of Alzheimer disease in a biracial urban community : relation to apolipoprotein E allele status", Arch Neurol, 60, pp.185~189 (2003)
71. Holtzman DM, "CSF biomarkers for Alzheimer’s disease: current utility and potential future use", Neurobiol Aging, 32(Suppl 1), pp.S4~S9 (2011)
72. Alzheimer A, "Die Seelenstorungen auf arteriscleroticsher Grundlage", Allgem Z Psychiatr Psych Gerichtl Med, 59, pp.695~711 (1902)
73. Weggen S, "Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer’s disease", Alzheimers Res Ther, 4, pp.9~ (2012)
74. Cataldo AM, "Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease : neuropathologic evidence for a mechanism of increased beta-amyloidogenesis", J Neurosci, 17, pp.6142~6151 (1997)
75. Cataldo AM, "Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome : differential effects of APOE genotype and presenilin mutations", Am J Pathol, 157, pp.277~286 (2000)
76. Fullerton SM, "Apolipoprotein E variation at the sequence haplotype level : implications for the origin and maintenance of a major human polymorphism", Am J Hum Genet, 67, pp.881~900 (2000)
77. McIntosh AM, "The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)", PLoS One, 7, pp.e47760~ (2012)
78. Finch CE, "Meat-adaptive genes and the evolution of slower aging in humans", Q Rev Biol, 79, pp.3~50 (2004)
79. Eisenberg DT, "Worldwide allele frequencies of the human apolipoprotein E gene : climate, local adaptations, and evolutionary history", Am J Phys Anthropol, 143, pp.100~111 (2010)
80. 권오대, "지역사회 거주 노인에서 인지기능과 아포지질단백질 E 유전자형의 연관성: 고령군 운수면 지역 조사", 대한신경과학회지, 27(4), pp.362~368 (2009), 대한신경과학회

관련 논문AI추천